• English
 
FacebookTwitterLinkedinVimeoYouTube
Azierta Science to BusinessAzierta Science to Business
Azierta Science to Business
    Menu
    • About us
        • Azierta
          • Corporate Information
          • quienessomosOur Team
          • Close
        • Clients
          • Our clients
          • opinion_menuTestimonials
          • Close
        • Locations
          • Madrid
            Vía de las Dos Castillas 33, Edificio 7 28224, Pozuelo de Alarcón Madrid,
            91 277 10 76
            info@azierta.eu
          • Barcelona
            Ctra. de l’Hospitalet, 147 Edificio Roma – 1ª Planta Parque Empresarial Citypark 08940, Cornellà de Llobregat, Barcelona
          • Bogotá
            Calle 25 nº 68-35
            Bogotá
            (+57) 310 34 98206

          • Portugal
            Avenida da Liberdade, 10
            1269-046 Lisboa
          • Italy
            Bastioni di Porta Nuova, 21
            20121, Milan
          • France
            54 rue de Londres
            75008, Paris,
            33 180 209 978
          • Close
      • Close
    • Our services
        • Toxicology
          • pdemenu2PDE/ADE Reports
          • Extractables and leachables impurities
          • oelmenu2OEL & API categorization
          • incorpapimenuAPI introduction in a multiproduct facility

          • evalimpOrganic and mutagenic impurities
          • Elemental impurities: ICHQ3D
          • ERA reports
          • pdemenunewChemical Industry: safety & hygiene support
          • Close
        • Regulatory Affairs
          • laberintorraaRegulatory Strategy
          • contenidos_cientificosManagement of procedures
          • documentacion_registroRegistration documents
          • mantenimiento_postautorizacionPost-Authorisation Maintenance

          • cumplimiento_regulatorioRegulatory Compliance
          • productos_sanitariosMedical Devices
          • Auditorias_dossieresAudits of Registration Dossiers
          • asesoria_regulatoriaRegulatory Counselling during Clinical Development
          • Close
        • Pharmacovigilance & Safety
          • Vigilazierta
          • img-screeningMLM/L2A Azierta Screening Tool
          • Local & European QPPV Support Service

          • Post-Marketing Pharmacovigilance Support
          • ensayosfvmenuPharmacovigilance in Clinical Trials
          • Audits & GVPs
          • Close
        • Medical Devices
          • Medical Compliance
          • Regulatory Consultancy (CE Marking)
          • Quality System (EN ISO 13485)
          • Intellectual property and patents
          • externalizaciondptotecnicov2Outsorcing of Technical Department

          • Authorized representatives services in europe
          • accesoalmercadov2Market Access Strategy
          • Post marketing surveillance
          • Export to USA (FDA)
          • Vigilance
          • Close
        • Medical Affairs
          • Medical Information Premium
          • mmaa3menuCompliance
          • Development and analysis of clinical research

          • mmaa4menuMedical-Marketing Strategies
          • analisisdelmercadomenuMarket Analysis
          • Close
        • Quality System
          • GDP implementation/support
          • gmpGMP implementation/support
          • calidad3GMP Quality System Implementation

          • Risk management
          • img-fda-menuFDA Regulation Services
          • Close
        • European Market Access
          • eumarketmenuEuropean Market Access
          • Close
      • Close
    • Azierta Blog
    • Careers
    • Contact us
      • I have read and I agree to the privacy policy

        AZIERTA CONTRACT SCIENTIFIC SUPPORT CONSULTING S.L. is responsible for the management of Users’ personal data and hereby informs Users that their data will be managed in conformity with what is set forth in current regulations concerning the protection of personal data, (EU) Regulation 2016/679, dated 27 April 2016 (GDPR) and Organic Law (ES) 15/1999, dated 13 December (LOPD in Spanish. You can consult the additional information on Data Protection on our website: Consent to the management of personal data via the website

        [recaptcha]

      • Close
    Menu
    • About us
        • Azierta
          • Corporate Information
          • quienessomosOur Team
          • Close
        • Clients
          • Our clients
          • opinion_menuTestimonials
          • Close
        • Locations
          • Madrid
            Vía de las Dos Castillas 33, Edificio 7 28224, Pozuelo de Alarcón Madrid,
            91 277 10 76
            info@azierta.eu
          • Barcelona
            Ctra. de l’Hospitalet, 147 Edificio Roma – 1ª Planta Parque Empresarial Citypark 08940, Cornellà de Llobregat, Barcelona
          • Bogotá
            Calle 25 nº 68-35
            Bogotá
            (+57) 310 34 98206

          • Portugal
            Avenida da Liberdade, 10
            1269-046 Lisboa
          • Italy
            Bastioni di Porta Nuova, 21
            20121, Milan
          • France
            54 rue de Londres
            75008, Paris,
            33 180 209 978
          • Close
      • Close
    • Our services
        • Toxicology
          • pdemenu2PDE/ADE Reports
          • Extractables and leachables impurities
          • oelmenu2OEL & API categorization
          • incorpapimenuAPI introduction in a multiproduct facility

          • evalimpOrganic and mutagenic impurities
          • Elemental impurities: ICHQ3D
          • ERA reports
          • pdemenunewChemical Industry: safety & hygiene support
          • Close
        • Regulatory Affairs
          • laberintorraaRegulatory Strategy
          • contenidos_cientificosManagement of procedures
          • documentacion_registroRegistration documents
          • mantenimiento_postautorizacionPost-Authorisation Maintenance

          • cumplimiento_regulatorioRegulatory Compliance
          • productos_sanitariosMedical Devices
          • Auditorias_dossieresAudits of Registration Dossiers
          • asesoria_regulatoriaRegulatory Counselling during Clinical Development
          • Close
        • Pharmacovigilance & Safety
          • Vigilazierta
          • img-screeningMLM/L2A Azierta Screening Tool
          • Local & European QPPV Support Service

          • Post-Marketing Pharmacovigilance Support
          • ensayosfvmenuPharmacovigilance in Clinical Trials
          • Audits & GVPs
          • Close
        • Medical Devices
          • Medical Compliance
          • Regulatory Consultancy (CE Marking)
          • Quality System (EN ISO 13485)
          • Intellectual property and patents
          • externalizaciondptotecnicov2Outsorcing of Technical Department

          • Authorized representatives services in europe
          • accesoalmercadov2Market Access Strategy
          • Post marketing surveillance
          • Export to USA (FDA)
          • Vigilance
          • Close
        • Medical Affairs
          • Medical Information Premium
          • mmaa3menuCompliance
          • Development and analysis of clinical research

          • mmaa4menuMedical-Marketing Strategies
          • analisisdelmercadomenuMarket Analysis
          • Close
        • Quality System
          • GDP implementation/support
          • gmpGMP implementation/support
          • calidad3GMP Quality System Implementation

          • Risk management
          • img-fda-menuFDA Regulation Services
          • Close
        • European Market Access
          • eumarketmenuEuropean Market Access
          • Close
      • Close
    • Azierta Blog
    • Careers
    • Contact us
      • I have read and I agree to the privacy policy

        AZIERTA CONTRACT SCIENTIFIC SUPPORT CONSULTING S.L. is responsible for the management of Users’ personal data and hereby informs Users that their data will be managed in conformity with what is set forth in current regulations concerning the protection of personal data, (EU) Regulation 2016/679, dated 27 April 2016 (GDPR) and Organic Law (ES) 15/1999, dated 13 December (LOPD in Spanish. You can consult the additional information on Data Protection on our website: Consent to the management of personal data via the website

        [recaptcha]

      • Close

Daily Archives: 31 January, 2018

You are here:
  1. Home
  2. 2018
  3. January
  4. 31

4 key points for a better understanding of ICH Q3D approach

Our experience with the implementation of ICH Q3D has showed that the new approach is not always well-understood by suppliers, probably due to the length and complexity of the guideline. This issue provokes a lot of time-consuming actions (hundreds of emails between customer-supplier, fulfilling questionnaires that are not enough for the drug product manufacturer, etc.).…

31 January, 2018Leave a commentToxicologyBy Azierta
Azierta Science to Business

Copyright © 2018 Azierta CSSC / Atreiza Laboratorios. Todos los Derechos Reservados.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More